Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
US Stock MarketDetailed Quotes
PHIN Phinia
- 44.010
- +1.330+3.12%
Close Apr 24 16:00 ET
- 44.000
- -0.010-0.02%
Post 16:22 ET
1.75BMarket Cap25.01P/E (TTM)
44.160High42.860Low403.44KVolume43.090Open42.680Pre Close17.60MTurnover1.17%Turnover Ratio25.01P/E (Static)39.80MShares56.91752wk High1.11P/B1.51BFloat Cap36.25352wk Low1.00Dividend TTM34.39MShs Float56.917Historical High2.27%Div YieldTTM3.05%Amplitude22.587Historical Low43.630Avg Price1Lot Size
Phinia Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 23.20%308M | 17.74%73M | -38.71%95M | 65.15%109M | 193.94%31M | -17.49%250M | -65.75%62M | 244.44%155M | 8.20%66M | -306.25%-33M |
| Net income from continuing operations | -22.55%79M | -84.85%5M | 3,200.00%31M | -60.00%14M | -17.14%29M | -61.07%102M | -56.00%33M | -101.12%-1M | -14.63%35M | -38.60%35M |
| Operating gains losses | --22M | --0 | --2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -6.43%160M | -13.33%39M | -4.76%40M | -6.98%40M | 0.00%41M | 0.59%171M | 12.50%45M | -2.33%42M | 0.00%43M | -6.82%41M |
| Deferred tax | -65.63%11M | -110.00%-3M | 216.67%7M | --3M | -50.00%4M | 28.00%32M | 20.00%30M | ---6M | --0 | --8M |
| Other non cash items | 64.29%-5M | 65.38%-9M | -66.67%2M | -116.67%-2M | 166.67%4M | -566.67%-14M | ---26M | --6M | --12M | -500.00%-6M |
| Change In working capital | 111.76%6M | 173.91%17M | -90.99%10M | 211.11%30M | 54.46%-51M | 70.52%-51M | -179.31%-23M | 230.59%111M | 15.63%-27M | -31.76%-112M |
| -Change in receivables | 88.61%149M | -65.84%69M | 203.39%61M | 296.43%55M | 0.00%-36M | 176.70%79M | 339.13%202M | 32.18%-59M | -1,500.00%-28M | 43.75%-36M |
| -Change in inventory | 675.00%23M | -62.50%21M | 75.00%-2M | 143.48%10M | 79.31%-6M | 93.33%-4M | 273.33%56M | -100.00%-8M | 23.33%-23M | 29.27%-29M |
| -Change in prepaid assets | -560.00%-33M | 107.14%2M | -850.00%-30M | 33.33%-4M | -104.00%-1M | -141.67%-5M | -40.00%-28M | -82.61%4M | -166.67%-6M | --25M |
| -Change in payables and accrued expense | -29.47%-123M | 69.32%-81M | -110.27%-19M | -207.41%-29M | 113.95%6M | -302.13%-95M | -2,500.00%-264M | 18,400.00%185M | 485.71%27M | -202.38%-43M |
| -Change in other working capital | 61.54%-10M | -45.45%6M | --0 | -166.67%-2M | 51.72%-14M | 62.32%-26M | 147.83%11M | 38.89%-11M | 150.00%3M | -31.82%-29M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 23.20%308M | 17.74%73M | -38.71%95M | 65.15%109M | 193.94%31M | -17.49%250M | -65.75%62M | 244.44%155M | 8.20%66M | -306.25%-33M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 32.67%-101M | 48.48%-17M | 32.43%-25M | 59.52%-17M | -10.53%-42M | -42.86%-150M | -32.00%-33M | -68.18%-37M | -100.00%-42M | -2.70%-38M |
| Capital expenditure reported | 30.00%-105M | 39.39%-20M | 32.43%-25M | 59.52%-17M | -13.16%-43M | -40.19%-150M | -57.14%-33M | -42.31%-37M | -82.61%-42M | -2.70%-38M |
| Net investment purchase and sale | 50.00%-1M | --0 | ---1M | ---- | ---- | ---2M | --0 | --0 | ---- | ---- |
| Net other investing changes | 150.00%5M | --3M | --1M | --0 | --1M | 0.00%2M | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 32.67%-101M | 48.48%-17M | 32.43%-25M | 59.52%-17M | -10.53%-42M | -42.86%-150M | -32.00%-33M | -68.18%-37M | -100.00%-42M | -2.70%-38M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -580.00%-96M | -16.67%-35M | 30.00%65M | -2,933.33%-85M | -1,266.67%-41M | 110.81%20M | 63.41%-30M | 50M | 105.26%3M | 93.48%-3M |
| Net issuance payments of debt | 104.60%178M | --0 | 5.41%156M | 108.33%25M | 95.71%-3M | 295.45%87M | -102.83%-3M | 825.00%148M | 400.00%12M | 27.08%-70M |
| Net common stock issuance | -783.33%-212M | -40.00%-21M | -766.67%-78M | ---90M | ---23M | ---24M | ---15M | ---9M | --0 | --0 |
| Cash dividends paid | -91.30%-44M | 0.00%-11M | 16.67%-10M | ---11M | ---12M | ---23M | ---11M | ---12M | --0 | --0 |
| Proceeds from stock option exercised by employees | -200.00%-3M | ---- | ---- | --0 | ---3M | ---1M | ---- | ---- | --0 | --0 |
| Net other financing activities | 21.05%-15M | --0 | 92.21%-6M | ---- | ---- | 90.82%-19M | --0 | -381.25%-77M | 83.02%-9M | 34.00%67M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -580.00%-96M | -16.67%-35M | 30.00%65M | -2,933.33%-85M | -1,266.67%-41M | 110.81%20M | 63.41%-30M | --50M | 105.26%3M | 93.48%-3M |
| Net cash flow | ||||||||||
| Beginning cash position | 45.42%365M | 29.97%477M | 59.15%339M | 79.56%325M | 45.42%365M | -3.09%251M | 115.88%367M | 26.04%213M | -6.22%181M | -3.09%251M |
| Current changes in cash | -7.50%111M | 2,200.00%21M | -19.64%135M | -74.07%7M | 29.73%-52M | 823.08%120M | -101.35%-1M | 630.43%168M | 258.82%27M | -10.45%-74M |
| Effect of exchange rate changes | 233.33%8M | -1,300.00%-14M | 121.43%3M | 40.00%7M | 200.00%12M | 71.43%-6M | -114.29%-1M | 36.36%-14M | 171.43%5M | 300.00%4M |
| End cash Position | 32.60%484M | 32.60%484M | 29.97%477M | 59.15%339M | 79.56%325M | 45.42%365M | 45.42%365M | 115.88%367M | 26.04%213M | -6.22%181M |
| Free cash flow | 103.00%203M | 82.76%53M | -40.68%70M | 283.33%92M | 83.10%-12M | -48.98%100M | -81.88%29M | 521.05%118M | -36.84%24M | -238.10%-71M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
